Study finds that the use of a digital therapeutics platform in people with obesity and metabolic syndrome can lead to a reduction in both weight and body mass index.
Your search for comorbidities returned 3 results
Click on a filter below to refine your search. Remove a filter to broaden your search.
Significant improvements to the management of metabolic syndrome after liver transplantation must be made to reduce the risk for CV events and mortality.
Glucose-lowering medications and high-intensity statins are not being used sufficiently among high-risk individuals with atherosclerotic cardiovascular disease and diabetes.
Latest News Your top articles for TuesdayFor More Personalized News
Haymarket Medical NetworkTop Picks
Continuing Medical Education (CME/CE) Courses